CLINICAL_TRIALS
trial_result
· 2022-07-01
Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes [Phase 3]
Summary
Phase 3 study of dulaglutide in children and adolescents with type 2 diabetes completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2022-07-01